A detailed history of Stonebrook Private Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Stonebrook Private Inc. holds 36,147 shares of MRK stock, worth $3.59 Million. This represents 1.09% of its overall portfolio holdings.

Number of Shares
36,147
Previous 37,372 3.28%
Holding current value
$3.59 Million
Previous $4.63 Billion 11.28%
% of portfolio
1.09%
Previous 1.33%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$111.15 - $128.97 $136,158 - $157,988
-1,225 Reduced 3.28%
36,147 $4.1 Billion
Q2 2024

Aug 06, 2024

BUY
$123.8 - $132.96 $136,922 - $147,053
1,106 Added 3.05%
37,372 $4.63 Billion
Q1 2024

May 07, 2024

BUY
$113.24 - $131.95 $214,363 - $249,781
1,893 Added 5.51%
36,266 $4.79 Billion
Q4 2023

Feb 05, 2024

BUY
$100.18 - $109.02 $3.44 Million - $3.75 Million
34,373 New
34,373 $3.75 Billion

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $251B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Stonebrook Private Inc. Portfolio

Follow Stonebrook Private Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stonebrook Private Inc., based on Form 13F filings with the SEC.

News

Stay updated on Stonebrook Private Inc. with notifications on news.